Results 101 to 110 of about 13,972,114 (292)

Pavee Point annual report 2003-2005 [PDF]

open access: yes, 2006
Introduction to Pavee Point Pavee Point is a national Traveller organisation whose staff and participants are Travellers and members of the majority population working together in partnership to address Travellers social and economic exclusion.
Pavee Point Travellers Centre
core  

Digital Cognitive Testing in Mitochondrial Disease: Validity and Challenges for Clinical Trial Use

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Primary mitochondrial disease is a group of genetic disorders caused by pathogenic variants in nuclear or mitochondrial DNA, often resulting in progressive neurodegeneration and cognitive decline. Current management is primarily supportive, though recent research offers hope for disease‐modifying treatments in the future.
Oksana Pogoryelova   +9 more
wiley   +1 more source

Gravity‐Dependent Modulation of Downbeat Nystagmus: Insights From Velocity‐Storage Dysfunction

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Downbeat nystagmus varies with head position, a phenomenon termed gravity‐dependent modulation. We aimed to clarify its mechanism using a velocity‐storage model. Methods In 10 patients with downbeat nystagmus due to cerebellar disorders, we recorded eye movements at different pitch‐ and roll‐axis head positions.
Ji‐Hyung Park   +5 more
wiley   +1 more source

Safety and Efficacy of GLP‐1 Receptor Agonists in Adults With Epilepsy, Obesity, and Type 2 Diabetes

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Managing obesity in patients with epilepsy is complicated by the weight‐gaining properties of essential antiseizure medications (ASMs) such as valproate and pregabalin. We evaluated the safety and efficacy of initiating glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) in this population.
Hyoshin Son   +3 more
wiley   +1 more source

Annual report 2003-2005 - Pavee Point

open access: yes, 2006
Pavee Point ...
Pavee Point Travellers Centre
core  

Immunosuppressive Drug Use in Limited Systemic Sclerosis: An International Survey

open access: yesArthritis Care &Research, EarlyView.
Objective Current guidelines recommend immunosuppressive treatment for diffuse cutaneous systemic sclerosis but are less clear on their use in limited cutaneous systemic sclerosis (lcSSc) in the absence of internal organ complications. We conducted an international survey to understand current immunosuppressive drug prescribing patterns in lcSSc ...
Sabrina Hoa   +3 more
wiley   +1 more source

Central Point Notice of Adopted Amendment (2008-05-19)

open access: yes, 2008
14 pp. Adopted 2008-05-19. Department of Land Conservation and Development Notice of Adopted AmendmentThe attached approved amendment is the updated population and demographic element of the City of Central Point Comprehensive Plan.
Central Point (Or.)
core   +1 more source

Central Point Notice of Adopted Amendment (2011-04-29)

open access: yes, 2011
65 pp. Adopted 2011-04-29. Department of Land Conservation and Development Notice of Adopted AmendmentRevision to the Flood Damage Prevention ordinance to make the revised Federal Emergency Management Agency (FEMA) Flood Insurance Rate Map (FIRM) panels ...
Central Point (Or.)
core   +1 more source

Pavee Point strategic plan 2006-2010

open access: yes, 2006
Pavee Point ...
Pavee Point Travellers Centre
core  

Generative AI Utilization and Perspectives Among Reproductive‐Age Women with Systemic Autoimmune and Rheumatic Diseases

open access: yesArthritis Care &Research, Accepted Article.
Objective Reproductive‐age women with systemic autoimmune and rheumatic diseases (SARDs) have unique information needs related to their SARDs and reproductive health. We sought to understand their use of and receptivity to current and hypothetical generative artificial intelligence (AI) tools for health information‐seeking. Methods We conducted a cross‐
Mariam Arif   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy